JPM Biotech ShowCase, CEO/Founder Dr. Zhong presented our first-in-class small molecular brain penetrable drugs indication around GBM. And our innovation drugs got a lots of attentions on the meeting, as the small molecular target drug is also one of the hot topics in the biotechnology field.